Hypolipidemic Activity of Cassia tora Seeds in Hyperlipidemic Rats

Indian Journal of Clinical Biochemistry

Volumn 30, Issue 1, 2015, Pages 78-83

  Awasthi, Vishnu Kumar ^a   Mahdi, Farzana ^a   Chander, Ramesh ^a   Khanna, Ashok Kumar ^b   Saxena, Jitendra Kumar ^b   Singh, Ranjana ^c   Mahdi, Abbas Ali ^c   Singh, Raj Kumar ^d  

^a Era's Lucknow Medical College and Hospital   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

^d Shri Mahant Indiresh Hospital   (India)

Author keywords

Cassia tora seeds; Cholesterol rich HFD; Hepatic LPL activity; Hepatic steatosis; Hypolipidemic agent; PHLA; Triton model of hyperlipidemia

Indexed keywords

EID: 84892743057     PISSN: 09701915     EISSN: 09740422     Source Type: Journal    
DOI: 10.1007/s12291-013-0412-2     Document Type: Article

References (30)

1. Warrier PK, Nambiar VPK, Ramankutty C. A text book of Indian medicinal plants, a compendium of 500 species. Orient Longman Private Limited: Chennai; 2001. 2:26.
2. Pawar HA, D’mello PM. Cassia tora Linn: an overview. Int J Pharmaceutical Sci Res. 2011;2(9):2286–91.
3. Chaurasia B, Dhakad RS, Dhakar VK, Jain PK. Preliminary phytochemical and pharmacological (Antidiabetic) screening of Cassia tora Linn. Int J of Pharm Life Sci. 2011;2(5):759–66.
4. Kee CH. The pharmacology of Chinese herbs. Boca Raton: CRC Press; 2001. p. 103.
5. Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart. 2008;94:16–26.
6. Mohammed K, Ali KM, Narayan V, Tandon N. Diabetes and coronary heart disease: current perspectives. Ind J Med Res. 2010;130:584–97.
7. Chattopadhyaya R, Pathak D, Jindal DP. Antihyperlipidemic agents. A review. Ind drugs. 1996;33:85–97.
8. Satyavati GV. Guggulipid: a promising hypolipedemic agent from gum guggul (Commiphora wightii). In: Economic and Medicinal Plant Research, editor. Plants and traditional medicine, vol. V. New York: Academic Press; 1991. p. 47–82.
9. Chander R, Khanna AK, Kapoor NK. Lipid lowering activity of guggulsterone from Commephora mukul in hyperlipidemic rats. Phytotherapy Res. 1996;10:508–11.
10. Wing DR, Robinson DS. Clearing factor lipase in adipose tissue. Biochem J. 1968;29:1798–803.
11. Deeg R, Ziegenborn J. Kinetic enzymatic method for automated determination of cholesterol in serum. Clin Chem. 1983;29:1798–803.
12. Zilversmith DB, Davis DK. Micro determination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med. 1950;35:155–60.
13. Buccolo G, David H. Quantitative determination of serum triglyceride by the use of enzymes. Clin Chem. 1973;19:476–80.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem. 1951;183:265–72.
15. Woodson RF. Statistical methods for the analysis of biochemical data. Chichester: Wiley; 1957. p. 315.
16. Schurr PE, Schultz JR, Parkinson TM. Triton induced hyperlipidemia in rats as an animal model for screening of hypolipermic drugs. Lipids. 1972;7:68–74.
17. Nityanand S, Kapoor NK. Case history of guggulipid –A hypolipidemic agent. In Han BH, Han DS, Han YN, Wox WS (editors) Proceedings of the fifth Asian symposium on Medicinal plants and species, Bangkok; 1966. p. 171–182.
18. Kumar V, Khan MM, Khanna AK, Chander R, Mahdi F, Mahdi AA, Saxena JK, Singh RK. Lipid lowering activity of Anthocephalus indicus root in hyperlipidemic rats. Evid Based Complement Altern Med. 2010;7(3):317–22.
19. Kumar V, Singh S, Khanna AK, Khan MM, Chander R, Mahdi F, Saxena JK, Singh S, Singh R, Singh RK. Hypolipidemic activity of Anthocephalus indicus (Kadam) in hyperlipidemic rats. Med Chem Res. 2008;17:152–8.
20. Brown MS, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science. 1986;232:34–47.
21. Patil UK, Saraf S, Dixit VK. Hypolipidemic activity of seeds of Cassia tora Linn. J Ethnopharmacol. 2004;90:249–52.
22. Cho IJ, Lee C, Ha TY. Hypolipidemic effect of soluble fiber isolated from seeds of Cassia tora Linn, in rats fed a high cholesterol diet. J Agric Food Chem. 2007;55(4):1592–6.
23. Chandan D, Sujit D, Charan SD, Arnabaditya M, Dolley R. Cassia tora: phyto-pharmacological overview. Int J Res Ayurveda and Pharmacy. 2011;2(4):1162–74.
24. Deoda RS, Kadam PV, Shivatare RS, Narappanawar NS, Yadav KN, Patil MJ. Pharmacognostic and phytopharmacological profile of Cassia tora Linn: a review. Inventi impact: Planta Activa. 2012, Article ID-Inventi:ppa/132/12. http://www.inventi.in/Article/ppa/132/12.aspx. Accessed 15 April 2012.
25. Wilkinson RE, Hardcastle WS. Comparative fatty acid contents of various organs of Cassia tora. Bot Gaz (Chicago). 1969;130:254.
26. Acharya TK, Chatterjee IB. Isolation of chrysophanic acid-9-anthrone, the major antifungal principle of Cassia tora. Lloydia. 1975;38:213.
27. Choi JS, Lee HJ, Park KY. In vitro antimutagenic effect of alateranin and rubrofusarin gentiobioside from roasted Cassia tora. Nat Prod Sci. 1998;4(2):100–4.
28. Hatani T, Hiroshi U, Hidey KI, Sumico S, Tomofusa T, Takashi Y. Phenolic constituents of Cassia seeds and antibacterial effect of some naphthalenes and anthraquinones on methicillin resistant Staphylococcus aureus. Chem Pharm Bull. 1999;47(8):1121–7.
29. Lee GY, Jang DS, Lee YM, Kim JM, Kim JS. Naphthopyrone glucosides from the seeds of Cassia tora with inhibitory activity on advanced glycation end products (AGEs) formation. Arch Pharm Res. 2006;29(7):587–90.
30. Ignacimuthu C, Dhanasekaran M, Agastian P. Potential hepatoprotective activity of ononitol monohydrate isolated from Cassia tora L on carbon tetrachloride induced hepatotoxicity in Wistar Rats. Phytomedicine. 2009;16:891–5.